Evidence map›Paper›PMID 28337196›Full record

ArticleFrontiers in immunology2017

Marisol Pérez-Toledo, Nuriban Valero-Pacheco, Rodolfo Pastelin-Palacios, Cristina Gil-Cruz, Christian Perez-Shibayama, Mario A Moreno-Eutimio, Ingeborg Becker, Sonia Mayra Pérez-Tapia, Lourdes Arriaga-Pizano, Adam F Cunningham and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
5.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Protein-centric mechanisms of typhoidalFrontiers in cellular and infection microbiology · 2026
    Review
  3. Protective IgM-mediated immunity againstFrontiers in immunology · 2025
    Article
  4. Article
  5. Optimization of EnterotoxigenicMicroorganisms · 2023
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Outer membrane proteins ofClinical and experimental vaccine research · 2021
    Article
  14. Article
  15. Article
  16. Deletion of theGut microbes · 2020
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 3 countries.

Marisol Pérez-ToledoMedical Research Unit on Immunochemistry, Specialties Hospital, National Medical Centre "Siglo XXI", Mexican Social Security Institute, Mexico City, Mexico; Departamento de Inmunología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City, Mexico.
Nuriban Valero-PachecoMedical Research Unit on Immunochemistry, Specialties Hospital, National Medical Centre "Siglo XXI", Mexican Social Security Institute, Mexico City, Mexico; Departamento de Inmunología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City, Mexico.
Rodolfo Pastelin-PalaciosFacultad de Química, Universidad Nacional Autónoma de México , Mexico City , Mexico.
Cristina Gil-CruzInstitute of Immunobiology, Kantonsspital St. Gallen , St. Gallen , Switzerland.
Christian Perez-ShibayamaInstitute of Immunobiology, Kantonsspital St. Gallen , St. Gallen , Switzerland.
Mario A Moreno-EutimioImmunity and Inflammation Research Unit, Hospital Juárez de México, Ministry of Health , Mexico City , Mexico.
Ingeborg BeckerFacultad de Medicina, Departamento de Medicina Experimental, Universidad Nacional Autónoma de México , Mexico City , Mexico.
Sonia Mayra Pérez-TapiaUnit of R&D in Bioprocesses (UDIBI), Department of Immunology, National School of Biological Sciences, National Polytechnic Institute , Mexico City , Mexico.
Lourdes Arriaga-PizanoMedical Research Unit on Immunochemistry, Specialties Hospital, National Medical Centre "Siglo XXI", Mexican Social Security Institute , Mexico City , Mexico.
Adam F CunninghamMRC Centre for Immune Regulation, College of Medical and Dental Sciences, Institute of Immunology and Immunotherapy, University of Birmingham , Birmingham , UK.
Armando IsibasiMedical Research Unit on Immunochemistry, Specialties Hospital, National Medical Centre "Siglo XXI", Mexican Social Security Institute , Mexico City , Mexico.
Laura C BonifazMedical Research Unit on Immunochemistry, Specialties Hospital, National Medical Centre "Siglo XXI", Mexican Social Security Institute , Mexico City , Mexico.
Constantino López-MacíasMedical Research Unit on Immunochemistry, Specialties Hospital, National Medical Centre "Siglo XXI", Mexican Social Security Institute, Mexico City, Mexico; Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Mexican Social Security Institute · MXInstituto Politécnico Nacional · MXKantonsspital St. Gallen · CHUniversidad Nacional Autónoma de México · MXHospital Juárez de México · MXTecnológico Nacional de México · MXUniversity of Birmingham · GB

Funding

Biotechnology and Biological Sciences Research Council BB/L009986/1
6 · The paper itself

Abstract

Several microbial components, such as bacterial DNA and flagellin, have been used as experimental vaccine adjuvants because of their inherent capacity to efficiently activate innate immune responses. Likewise, our previous work has shown that the major

Indexed as

adjuvantsantibody responsesIFN-gammaIL-17influenzaporinsVi polysaccharide

Identifiers

PMID28337196
PMCPMC5344031
OpenAlexW2594383219

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.